Abstract
ABSTRACT Several years ago triethanomelamine (2,4,6-tri(ethyleneimino)-l,3,5-triazine, or TEM) was introduced into clinical chemotherapy for its tumour-inhibiting property. It was found, in addition, that TEM is a strong mutagenic factor.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
